Journal Publications

Project Data Sphere's success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.

Article Title Journal
Impact of Time to Start Systemic Therapy on the Outcomes of Patients with Metastatic Colorectal Cancer Treated with First Line FOLFOX Chemotherapy; a Patient-Level Pooled Analysis of Two Clinical Trials Expert Review of Gastroenterology and Hepatology
Association Between RECIST Changes and Survival in Patients with Metastatic Castration-resistant Prostate Cancer Receiving Docetaxel European Urology
Nonparametric tests for multistate processes with clustered data AISM
KMDATA: a curated database of reconstructed individual patient-level data from 153 oncology clinical trials Database
Proton Pump Inhibitors and Survival in Patients With Colorectal Cancer Receiving Fluoropyrimidine-Based Chemotherapy Journal of the National Comprehensive Cancer Network
Impact of single-agent daily prednisone on outcomes in men with metastatic castration-resistant prostate cancer Prostate Cancer and Prostatic Diseases
The menopause after cancer study (MACS) - A multimodal technology assisted intervention for the management of menopausal symptoms after cancer – Trial protocol of a phase II study Contemporary Clinical Trials Communications
Machine Learning Predicts Outcomes of Phase III Clinical Trials for Prostate Cancer Algorithms
Metastatic Merkel Cell Carcinoma Masquerading as Multiple Immune-Related Adverse Events Case Reports in Dermatological Medicine
Potential evidence of peritoneal recurrence in Stage-II colon cancer from the control arm of CALGB9581 The American Journal of Surgery
Efficacy and adverse events of docetaxel for metastatic, hormone-sensitive prostate cancer among elderly men: post-hoc analysis of CHAARTED trial Clinical Genitourinary Cancer
Characteristics of available studies and dissemination of research using major clinical data sharing platforms Clinical Trials
Predicting survival time for metastatic castration resistant prostate cancer: An iterative imputation approach F1000 Research
Cancer patient survival can be parametrized to improve trial precision and reveal time-dependent therapeutic effects Nature Communications

Pages